FindTrial
Sign In

Study on the clinical usefulness of preoperative blood marker (Fibrinogen-to-Albumin Ratio) to predict long-term survival and Graft failure in Living Donor Liver Transplantation patients

Preoperative Fibrinogen-to-Albumin Ratio as a Predictor of Overall Mortality and Graft Failure in Living Donor Liver Transplantation: A Propensity Score-Matched Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0011742
Enrollment
9000
Registered
2026-03-18
Start date
2026-03-17
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult men and women aged =18 years who underwent living-donor liver transplantation at Asan Medical Center, Samsung Medical Center, and Haeundae Paik Hospital between January 2 2008 and December 31, 2025.

Exclusion criteria

Exclusion criteria: Liver retransplantation Toxic liver failure Fulminant hepatitis Acute-on-chronic liver failure

Design outcomes

Primary

MeasureTime frame
Overall mortality—

Secondary

MeasureTime frame
Graft failure—

Countries

Korea, Republic of

Contacts

Public ContactJun-Gol Song

Asan Medical Center

jungol.song@amc.seoul.kr+82-2-3010-3869

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Apr 3, 2026